Financial Year |
March 31 2023 |
Monetary Funds |
457,139,197.97 |
Held-for-trading Financial Assets |
15,000,000.00 |
Notes Receivable |
5,995,396.20 |
Accounts Receivable |
215,736,117.58 |
Advances to Suppliers |
48,878,956.35 |
Other Receivables |
4,638,262.21 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
152,488,941.91 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
9,821,707.30 |
Total Current Assets |
920,863,473.11 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
8,006,376.03 |
Investment Properties |
-- |
Fixed Assetes |
271,963,407.13 |
Under-construction Projects |
12,960,131.68 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
62,415,520.00 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
9,026,014.65 |
Deferred Income Tax Assets |
4,499,017.53 |
Other Non-Current Assets |
36,096,741.25 |
Sub-Total of Non-Current Assets |
408,670,670.60 |
Total Assets |
1,329,534,143.71 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
128,372,430.77 |
Accounts Payable |
140,575,982.60 |
Accounts Received In Advance |
5,714.29 |
Employee Compensation Payable |
26,400,755.33 |
Taxes Payable |
5,188,341.58 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
1,419,138.63 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
124,970.71 |
Other Current Liabilities |
6,708,039.28 |
Sub-Total of Current Liabilities |
323,824,748.41 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
4,930,175.70 |
Deferred Income Tax Liabilities |
27,420.28 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
13,079,027.64 |
Total Liabilities |
336,903,776.05 |
Paid-In Capital(Or Share Stock) |
204,429,420.00 |
Capital Surplus |
317,223,396.14 |
Surplus Reserve |
54,015,010.73 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
416,962,540.79 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
992,630,367.66 |
Owner's Equity(Stockholder's Equity) |
992,630,367.66 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,329,534,143.71 |